HOME >> BIOLOGY >> TECHNOLOGY |
NEW YORK and BARCELONA, Spain, May 15 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX), and Laboratorios Almirall, S.A. (ALM.MC) will host a webcast to discuss aclidinium bromide clinical and pre-clinical data findings presented at the American Thoracic Society Annual Congress. The webcast, which will include a slide presentation and a Q&A session, will occur on Wednesday, May 21, 2008 at 9:30am New York time, 3:30pm CET, 2:30pm UKT.
(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )
Representing Almirall will be Per-Olof Andersson, Executive Director,
Research and Development, Gonzalo de Miquel, Global Medical Director and
Jordi Beleta, Director of Biology of Almirall. Representing Forest
Laboratories will be Dr. Lawrence Olanoff, President and Chief Operating
Officer of Forest.
The webcast can be accessed at the URL: http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=83198&eventID=1853706 (Due to the length of the link, please copy and paste into your browser.)
Live audio-only access to the webcast can be obtained by dialing the
following phone numbers:
For U.S. participants: 866.831.6162
For all international participants: +617.213.8852
The webcast will be available on Forest Laboratories' and Almirall's websites at http://www.frx.com and http://www.almirall.com the same date.
A replay of the webcast will be available on both websites.
An audio-only replay will be available until May 28, 2008 and can be
accessed by dialing the following phone numbers: The passcode is 52634048
For U.S. participants: 888-286-8010
For all international participants: + 617-801-6888
SOURCE Forest Laboratories, Inc. Copyright©2008 PR Newswire. All rights reserved |